First Time Loading...

Kunshan Kersen Science & Technology Co Ltd
SSE:603626

Watchlist Manager
Kunshan Kersen Science & Technology Co Ltd Logo
Kunshan Kersen Science & Technology Co Ltd
SSE:603626
Watchlist
Price: 6.39 CNY -0.31% Market Closed
Updated: May 7, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

5.4B
+0%
Assets
Growth Rates:
1 Year
-6%
3 Years
-6%
5 Years
+39%
7 Years
+313%
10 Years
-
2.4B
+4%
Liabilities
Growth Rates:
1 Year
-9%
3 Years
-31%
5 Years
+15%
7 Years
+220%
10 Years
-
2.9B
-3%
Equity
Growth Rates:
1 Year
-4%
3 Years
+34%
5 Years
+68%
7 Years
+443%
10 Years
-

Balance Sheet Decomposition
Kunshan Kersen Science & Technology Co Ltd

5.4B
Assets
2.4B
Liabilities
5.4B
Assets
2.4B
Liabilities
Current Assets 2.1B
Cash & Short-Term Investments 373.3m
Receivables 1.3B
Other Current Assets 402.5m
Non-Current Assets 3.3B
Long-Term Investments 245.7m
PP&E 2.8B
Intangibles 164m
Other Non-Current Assets 91m
Current Liabilities 1.5B
Accounts Payable 757.1m
Accrued Liabilities 62.9m
Short-Term Debt 482.6m
Other Current Liabilities 211.4m
Non-Current Liabilities 902.1m
Long-Term Debt 754.8m
Other Non-Current Liabilities 147.3m

Balance Sheet
Kunshan Kersen Science & Technology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
25
45
91
83
433
631
116
280
413
409
Cash
0
0
0
0
0
0
0
0
413
409
Cash Equivalents
25
45
91
83
433
631
116
280
0
0
Total Receivables
130
230
649
586
1 277
1 470
1 111
1 738
1 980
1 504
Accounts Receivables
120
225
631
567
1 171
1 357
1 022
1 626
1 931
1 467
Other Receivables
10
5
18
19
105
114
90
112
49
37
Inventory
18
34
59
86
169
315
192
506
370
335
Other Current Assets
4
4
11
6
12
16
19
29
46
29
Total Current Assets
177
313
810
761
1 890
2 432
1 438
2 552
2 808
2 277
PP&E Net
122
230
465
638
1 450
2 320
2 784
3 085
2 546
2 955
PP&E Gross
122
230
465
0
1 450
2 320
2 784
3 085
2 546
2 955
Accumulated Depreciation
15
30
63
0
202
497
694
951
1 210
1 590
Intangible Assets
10
33
52
79
78
150
178
174
121
168
Long-Term Investments
3
3
3
3
3
5
137
142
484
238
Other Long-Term Assets
3
3
6
10
20
55
61
75
73
61
Total Assets
315
N/A
581
+84%
1 335
+130%
1 490
+12%
3 441
+131%
4 961
+44%
4 598
-7%
6 028
+31%
6 032
+0%
5 699
-6%
Liabilities
Accounts Payable
81
140
329
337
630
846
979
1 383
977
869
Accrued Liabilities
11
13
52
38
46
62
58
76
58
68
Short-Term Debt
46
155
307
255
753
1 175
1 095
1 386
947
541
Current Portion of Long-Term Debt
14
20
15
0
0
90
0
37
34
415
Other Current Liabilities
10
13
76
70
98
70
37
83
98
51
Total Current Liabilities
161
342
779
700
1 526
2 243
2 169
2 965
2 115
1 943
Long-Term Debt
0
0
69
90
90
614
555
567
786
506
Deferred Income Tax
0
0
0
3
6
22
33
39
39
46
Minority Interest
0
0
0
0
0
87
42
35
0
0
Other Liabilities
23
20
69
92
61
131
140
331
98
99
Total Liabilities
184
N/A
362
+97%
917
+153%
884
-4%
1 683
+90%
3 097
+84%
2 939
-5%
3 936
+34%
3 038
-23%
2 595
-15%
Equity
Common Stock
65
79
79
158
297
416
424
491
558
557
Retained Earnings
56
74
273
443
632
682
394
346
715
802
Additional Paid In Capital
11
66
66
5
829
714
761
1 301
1 749
1 758
Treasury Stock
0
0
0
0
0
41
0
47
28
14
Other Equity
0
0
0
0
0
94
80
0
0
0
Total Equity
131
N/A
219
+67%
417
+90%
606
+45%
1 758
+190%
1 865
+6%
1 659
-11%
2 091
+26%
2 994
+43%
3 104
+4%
Total Liabilities & Equity
315
N/A
581
+84%
1 335
+130%
1 490
+12%
3 441
+131%
4 961
+44%
4 598
-7%
6 028
+31%
6 032
+0%
5 699
-6%
Shares Outstanding
Common Shares Outstanding
127
155
155
310
416
413
424
491
552
554

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.